SPRY Lowers Guidance
ARS Pharmaceuticals lowers FY26 cash operating expense guidance, shares trade lower
ARS Pharmaceuticals shares are trading lower.
The company lowered its FY26 cash operating expense guidance.
ARS Pharmaceuticals lowers FY26 cash operating expense guidance, shares trade lower
ARS Pharmaceuticals shares are trading lower.
The company lowered its FY26 cash operating expense guidance.